At Endomag, we believe everyone deserves a better standard of cancer care. Many of the world’s leading physicians and hospitals use our magnetic technologies to help breast cancer patients avoid surgery when it isn’t needed, and experience better outcomes when it is.

One of these technologies is Magtrace® lymphatic tracer, the world’s first, long-lasting, non-radioactive dual tracer for lymphatic mapping. With its longer injection window, it is now allowing surgeons to avoid unnecessary lymph node surgery in some cases, reducing the risk of lymphedema, thanks to the revolutionary ‘delayed’ sentinel lymph node biopsy procedure.

Find out more at www.endomag.com

 

Speak with one of our team

Wess Dodge, Strategic Account Manager (East)

Email: wdodge@endomag.com

Phone: 603-930-7884

Contact Us

Please enter your name.
Please enter a subject.
Please enter a valid phone number.
Please enter a message.

What is ‘Delayed’ Sentinel Lymph Node Biopsy? Watch our explainer

Or download one of our Magtrace® brochures